首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal PIAS2 Antibody

  • 中文名: PIAS2抗体
  • 别    名: DIP; MIZ; MIZ1; SIZ2; ARIP3; PIASX; ZMIZ4; PIASX-BETA; PIASX-ALPHA
货号: IPDX04606
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/1000-1/5000 Human,Mouse,Rat

产品详情

AliasesDIP; MIZ; MIZ1; SIZ2; ARIP3; PIASX; ZMIZ4; PIASX-BETA; PIASX-ALPHA
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenSynthetic peptide of human PIAS2
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是3篇与PIAS2抗体相关的文献摘要(虚拟示例,供参考):

1. **文献名称**: "PIAS2-mediated SUMOylation regulates STAT1 signaling in inflammatory responses"

**作者**: Lee et al. (2020)

**摘要**: 研究利用PIAS2特异性抗体,通过免疫共沉淀技术揭示了PIAS2在巨噬细胞中通过SUMO化修饰STAT1调控炎症信号通路的分子机制。

2. **文献名称**: "A novel PIAS2 antibody validates its nuclear localization in glioblastoma cells"

**作者**: Zhang et al. (2019)

**摘要**: 报道了一种高特异性PIAS2抗体的开发,并通过免疫荧光和Western blot证实PIAS2在胶质母细胞瘤细胞核内的异常表达,提示其潜在肿瘤调控作用。

3. **文献名称**: "PIAS2 interacts with p53: Evidence from co-immunoprecipitation using anti-PIAS2 antibodies"

**作者**: Müller et al. (2018)

**摘要**: 使用PIAS2抗体进行免疫沉淀实验,首次证明PIAS2与肿瘤抑制蛋白p53的直接相互作用,并调控其转录活性及细胞凋亡功能。

---

注:以上文献为示例性质,实际引用需查询PubMed等数据库获取真实研究(可尝试关键词:**PIAS2 antibody, PIAS2 SUMO, PIAS2 immunoprecipitation**)。

背景信息

The PIAS2 (Protein Inhibitor of Activated STAT2) antibody is a crucial tool in studying the PIAS family of proteins, which regulate various cellular processes, including signal transduction, transcriptional regulation, and post-translational modifications. PIAS2 functions as an E3 SUMO ligase, modulating the activity of transcription factors such as STATs, NF-κB, and p53 through SUMOylation. It plays roles in inflammation, immune responses, apoptosis, and DNA repair. The antibody specifically targets PIAS2 isoforms (PIAS2α and PIAS2β) to detect their expression, localization, and interactions in experimental models like Western blotting, immunofluorescence, and immunoprecipitation. Research using PIAS2 antibodies has highlighted its involvement in cancer progression, neurodegenerative diseases, and autoimmune disorders. For instance, dysregulated PIAS2 expression correlates with tumor suppression or promotion, depending on cellular context. Commercially available PIAS2 antibodies are typically developed in hosts like rabbits or mice, validated for specificity using knockout controls or siRNA. Challenges include cross-reactivity with other PIAS family members, necessitating careful validation. Ongoing studies aim to clarify PIAS2's dual roles and therapeutic potential, making its antibody a vital reagent in molecular and pathological research.

客户数据及评论

折叠内容

大包装询价

×